跳至主要内容
临床试验/CTRI/2015/10/006257
CTRI/2015/10/006257已完成4 期

A Randomised Controlled Trial to compare the efficacy and safety of Alternate day Vs. Daily Levamisole in Frequently Relapsing and Steroid Dependent Nephrotic Syndrome - LEV/FRNS-SDNS

Dr Sushmita Banerjee0 个研究点目标入组 196 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
196

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with Frequently Relapsing or Steroid Dependent Nephrotic Syndrome attending outpatients’ clinic with a relapse. All patients should have normal blood pressure, creatinine, C3 and ANA and be Hep.BsAg. negative.

排除标准

  • Secondary nephrotic syndromes, steroid resistant nephrotic syndrome, any active infection, and patients who have received previous therapy with Mycophenolate mofetil, Cyclosporine A or Tacrolimus.

研究者

发起方
Dr Sushmita Banerjee

相似试验